ADAR1 Capital Management reports acquisition of $34,571.592 in Mentari Therapeutics common shares
MTRI•ADAR1 Capital Management purchased 2,640 Mentari Therapeutics common shares at $13.0953 per share, bringing its indirect beneficial ownership to 98,297 shares.
1. Share purchase
ADAR1 Capital Management reported purchasing 2,640 Mentari Therapeutics common shares at $13.0953 per share, for a total of $34,571.592. Indirect beneficial ownership totaled 98,297 shares after the purchase. Daniel Schneeberger, the firm's manager and a joint reporting owner, was listed as a 10% owner.
